This prospectus is a culmination of input from Stop TB Partners including representatives from TB high-burden countries, UN agencies, Nongovernmental Organizations (NGOs), and foundations to develop the form, strategies, objectives, and governance of the Global TB Drug Facility (GDF).
This report summarizes the accomplishments and activities of the Stop TB Partnership in 2001.
This flash movie is an informational film based on the report "Tuberculosis" published by WHO. The movie puts a human face on the TB epidemic and the deadly interaction between TB and HIV. It depicts the suffering of people affected by this disease through images and interviews. Outlining the efficacy of the DOTS program, the movie makes clear that continued commitment and expanded resources are vital to combat TB.
This guide assists in making TB control policy decisions and plans for successfully introducing fixed-dose combination drugs (FDCs). This guide is intended for national TB program managers, DOTS strategy implementers, drug procurement officers/personnel, DOT providers, and drug regulatory authorities.
This report highlights the work of community-based organizations and people living with HIV/AIDS in advocating for coordinated TB and HIV policies and services in their countries. The report presents case studies from Indonesia, Mexico, Sierra Leon, South Africa, Ukraine, and the Caribbean, highlighting community advocates’ strategies, achievements, and lessons learned.
The Stop TB Department (STB) of the World Health Organization (WHO), in collaboration with technical partners, has revised the TB recording and reporting (R&R) system to align the forms and registers with the new Stop TB Strategy. The revision facilitates the monitoring of the six components of the Stop TB Strategy, which itself was developed to help achieve the Millenium Development Goals.
This report summarizes the accomplishments and activities of the Stop TB Partnership in 2011.
This group of four fact sheets explain the origin and purpose of the Global Drug Facility (GDF), how the GDF works, how to apply to the GDF for a grant of TB drugs, and how to buy drugs through the GDF.
This guide is divided into three major parts. The first part is designed to provide the Contact Investigator with the essential HIV/AIDS information he or she will need when engaging in a family-friendly discussion to encourage TB contacts to agree to HIV counseling and testing. The second is designed to give TB program managers guidelines for implementing a program tailored to their jurisdiction. The third part details a training course that will impart the skills, attitudes, and knowledge one will need to include HIV in tuberculosis contact investigations.
This report presents the recommendations by the 2nd ad hoc Committee on the TB epidemic.
